Results 131 to 140 of about 1,510 (191)

Comparing the effectiveness of four antihistamines with olopatadine in healthy Thoroughbred horses.

J Vet Med Sci
Ikeda Y, Kuroda T, Mita H, Tamura N, Ohta M.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

A Review of Olopatadine for the Treatment of Ocular Allergy

Expert Opinion on Pharmacotherapy, 2004
Ocular allergy affects > 20% of the general population and many therapeutic preparations are available to individuals experiencing the most common forms--seasonal and perennial allergic conjunctivitis. 0.1% Olopatadine topical ophthalmic solution is currently approved for the treatment of allergic signs and symptoms in patients > or = 3 years of age ...
Mark B Abelson
exaly   +3 more sources

A review of the use of olopatadine in allergic conjunctivitis

International Ophthalmology, 2004
Ocular allergies are very common and range in intensity from mild, self-resolving, acute conditions to serious, chronic disease that can severely affect vision. The vast majority of sufferers experience relatively mild symptoms, which are often seasonal in nature. Treatments should be simple, comfortable and very safe. They should be able to respond to
McGill, James I.
openaire   +4 more sources

Pharmacokinetics of Intranasal Olopatadine in the Fixed-Dose Combination GSP301 Versus Two Monotherapy Intranasal Olopatadine Formulations

Allergy and Asthma Proceedings, 2018
GSP301 is a fixed-dose combination of the antihistamine olopatadine hydrochloride and the corticosteroid mometasone furoate developed as a single nasal spray.To assess the relative bioavailability of olopatadine administered as GSP301 versus two olopatadine monotherapy nasal spray formulations.In this single-dose, open-label, crossover study, healthy ...
Anne Marie Salapatek, Piyush Patel, Sudeesh K Tantry   +2 more
exaly   +3 more sources

Olopatadine/Mometasone (Ryaltris) for Allergic Rhinitis

The Medical Letter on Drugs and Therapeutics, 2023
The FDA has approved Ryaltris (Hikma), a fixed-dose combination nasal spray containing the H1-antihistamine olopatadine hydrochloride (Patanase, and generics) and the corticosteroid mometasone furoate (Nasonex 24 HR Allergy, and generics), for treatment of seasonal allergic rhinitis symptoms in persons ≥12 years old.
openaire   +2 more sources

Ocular allergy treatment comparisons: Azelastine and olopatadine

Current Allergy and Asthma Reports, 2004
Azelastine hydrochloride 0.05% and olopatadine hydrochloride 0.1% are topical ocular allergy treatments that have demonstrated multiple pharmacologic actions, including antihistamine, mast cell stabilization, and inhibition of proinflammatory mediators.
Leonard, Bielory, Praveen, Buddiga, Stephen, Bigelson   +2 more
openaire   +2 more sources